Valheart Contraindications

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Contraindications

Hypersensitivity to ivabradine or to any ingredient in the product.
Resting heart rate below 70 beats per minute prior to treatment.
Cardiogenic shock.
Acute myocardial infarction.
Severe hypotension (<90/50 mmHg).
Severe hepatic impairment.
Sick sinus syndrome.
Sinoatrial block.
Unstable or acute heart failure.
Pacemaker dependence (heart rate imposed exclusively by the pacemaker).
Unstable angina.
Third degree atrioventricular (AV) block.
Patients with existing prolonged QT interval (e.g., congenital long QT syndrome).
Concomitant use with strong CYP3A4 inhibitors such as azole antifungals (ketoconazole, itraconazole), macrolide antibiotics (clarithromycin, oral erythromycin, josamycin, telithromycin), HIV protease inhibitors (nelfinavir, ritonavir) and nefazodone.
Concomitant use with moderate CYP3A4 inhibitors with heart reducing properties (e.g., verapamil or diltiazem).
Pregnancy and lactation.

ivabradine

Manufacturer:

KRKA

Distributor:

UNILAB, Inc